Genetic switch turns tumor suppressor into oncogene in colorectal cancer
Colorectal cancer (CRC) is a leading cause of cancer deaths worldwide, and only around 10% of patients survive for five years after being diagnosed.
Sep 11, 2023
0
39
Colorectal cancer (CRC) is a leading cause of cancer deaths worldwide, and only around 10% of patients survive for five years after being diagnosed.
Sep 11, 2023
0
39
A new editorial paper titled "Subpopulations of AIB1 isoform-expressing breast cancer cells enable invasion and metastasis" has been published in Oncotarget.
Sep 6, 2023
0
0
A new cancer therapy developed by Purdue University researchers attacks tumors by tricking cancer cells into absorbing a snippet of RNA that naturally blocks cell division. As reported in Oncogene, tumors treated with the ...
Sep 4, 2023
0
172
Vitamin C and other antioxidants stimulate the formation of new blood vessels in lung cancer tumors, a new study from Karolinska Institutet published in the Journal of Clinical Investigation shows. The discovery corroborates ...
Aug 31, 2023
0
409
A research team led by Professor Judy Yam Wai-ping from the Department of Pathology, School of Clinical Medicine, LKS Faculty of Medicine, the University of Hong Kong (HKUMed) has made a significant breakthrough in unveiling ...
Aug 30, 2023
0
36
You may know it as an aromatic spice to add flavor to your dishes or as a soothing herbal remedy to use for upset stomachs, but researchers from Osaka Metropolitan University have uncovered promising findings that Kencur, ...
Aug 28, 2023
0
15
Researchers at the University of Florida College of Medicine have discovered how common age-related changes in the blood system can make certain colon cancers grow faster.
Aug 24, 2023
0
29
To improve therapies for cancer and other diseases, researchers strive to identify tissue-specific therapeutic targets and diagnostic biomarkers in every patient. Identifying specific targets and biomarkers can be achieved ...
Aug 22, 2023
0
36
Anti-estrogenic therapies can suppress the growth of cancer that does not express estrogen receptors; when combined with immune checkpoint inhibitor therapies, they halt tumor progression in mice models.
Aug 21, 2023
0
49
A new editorial paper was published in Oncotarget, titled "Inhibition of glutamine metabolism: acting on tumoral cells or on tumor microenvironment?"
Aug 16, 2023
0
1